Percutaneous balloon pulmonary valvuloplasty of critical pulmonary stenosis and severe pulmonary stenosis in neonates and early infancy: A challenge in the cyanotic by Mortezaeian, H. et al.
J Cardiovasc Thorac Res, 2021, 13(2), 156-161
doi: 10.34172/jcvtr.2021.33
http://jcvtr.tbzmed.ac.ir
Percutaneous Balloon Pulmonary Valvuloplasty of Critical 
Pulmonary Stenosis and severe pulmonary stenosis in Neonates and 
Early Infancy: A Challenge in the Cyanotic
Hojjat Mortezaeian1 ID , Mohammadrafie Khorgami1* ID , Negar Omidi2, Yasaman Khalili1, Maryam Moradian1, 
Raheleh Zamani1, Esfandyar Nazari1
1Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran 
2Cardiac Primary Prevention Research Center, Tehran Heart Center and Department of Cardiology, School of Medicine, Tehran 
University of Medical Sciences, Tehran, Iran
Introduction
Pulmonary stenosis with intact ventricular septum 
(PS-IVS) is one of the frequent causes of cyanotic heart 
disease in neonates and infants,1 requiring prompt 
management. Also, it is not a unique term because the 
diverse morphologies of this disorder call for different 
management approaches and its exact diagnosis requires 
the evaluation of clinical information, echocardiographic 
findings, and catheterization data.2
The size of the right ventricular (RV) cavity, size of 
the infundibulum of the right ventricular outflow tract 
(RVOT), and diameter of the tricuspid valve (TV) are 
important landmarks. Other variables with major roles in 
this regard include the right-to-left ventricular (RV/LV) 
pressure ratio, ductal prostaglandin dependency, severity 
of the clinical manifestations, and associated anomalies.
Until recently, surgical pulmonary valvotomy aimed at 
increasing the pulmonary blood flow was the treatment 
of choice; nevertheless, transcatheter balloon pulmonary 
valvuloplasty (BPV) is now the standard therapy for this 
disorder.3,4
The decompression of the RV with BPV with or 
without ductal stenting has been accompanied by various 
short- and long-term prognoses in different studies.5-7 
Accordingly, we sought to evaluate both the short- and 
midterm results of Balloon pulmonary valvuloplasty in 45 
neonates and infants with PS-IVS and the effects of our 
interventional procedures on the patients’ outcome.
Materials and Methods
This study was a prospective review that 45 patients 
less than 6 months old admitted to our Center with a 
diagnosis of PS-IVS between May 2012 and July 2016 were 
evaluated. This study was approved by university ethical 
committee according to the Helsinki Declaration of the 
World Medical Association (Ethic code number:IR.RHC.
REC.1391.70). Informed consent was obtained from the 
parents. Prostaglandin E1 (PGE1) was initiated if the level 
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Introduction: Pulmonary stenosis with an intact ventricular septum (PS-IVS) is one of the common 
causes of cyanotic heart disease in neonates with diverse morphologies as well as management and 
treatment protocols. The aim of this study was to evaluate short and midterm results of balloon 
pulmonary valvuloplasty (BPV) for this disorder.
Methods: Between 2012 and 2016, Totally 45 neonates and infants under 6 months old were evaluated. 
The patients had a minimum right-to-left ventricular pressure ratio of 1, right-to-left shunting at the 
patent foramen ovale or atrial septal defect level, and tricuspid valve Z-scores higher than -4. 
Results: Immediately after the procedure, the right ventricular pressure dropped to the normal values 
in 8 (20%) patients. The immediate procedural success rate was seen in 42 (93.3%) cases: the right-to-
left ventricular pressure ratio dropped to below 50% or the level of O2 saturation rose above 75%. Of 
three cases unresponsive to BPV, two of them underwent patent ductus arteriosus (PDA) stenting and 
one procedural death occurred. At 6 months’ follow-up, of 42 patients, this pressure was still within 
the normal range in 36 (80%) infants, while it had returned to high values in 9 (20%) patients and 
necessitated repeat valvuloplasty. After BPV, severe pulmonary valve regurgitation was observed in 
14.2% patients; the condition was more common when high-profile noncompliant balloons were used.
Conclusion: Balloon pulmonary valvuloplasty in infants with PS-IVS confers acceptable results insofar 
as it improves echocardiographic parameters and hemodynamic changes at short- and midterm follow-
ups. Balloon selection with sizes more than 1.2 of the diameter of the pulmonary valve annulus and 
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of O2 saturation was below 75%.
The inclusion criteria comprised age under six 6 
months old, severe PS, RV/LV pressure ratio equal to 
or higher than 1, right-to-left shunting at the patent 
foramen ovale (PFO) or atrial septal defect level (ASD), 
and tricuspid valve Z-score greater than -4. The exclusion 
criteria consisted of stenosis of the supra-pulmonary valve 
and the peripheral pulmonary branches, association with 
other structural heart diseases, tricuspid valve Z-score less 
than -4, hypoplastic right ventricle, and right ventricle- 
dependent coronary perfusion.
The echocardiographic examinations were performed 
by a single operator using a Vivid 7 system (Vingmed 7; GE 
Medical System, Inc, Horten, Norway). The pulmonary 
valve was considered dysplastic when the valve was thick 
and had low motion with a small annulus size without 
post-stenotic dilation in the main pulmonary artery (PA). 
The size of the RV and the normality of the 3 segments of 
the right ventricle chamber (i.e., inlet, apex, and outlet) 
were assessed. In addition, the diameter of the tricuspid 
valve annulus was measured in the 4-chamber view and 
the tricuspid valve Z-score was calculated according to the 
patients’ body surface area and appropriate tables.8
Six months after pulmonary valvuloplasty, RV/LV 
pressure ratio was calculated by echocardiography. 
The pressure gradient across the pulmonary valve was 
measured by considering the pulmonary artery pressure 
normal in this group of patients, and the RV pressure 
was determined. In the presence of tricuspid valve 
regurgitation, the RV pressure was measured based on 
Bernoulli equation. Furthermore, the systolic aortic 
pressure was measured for the assessment of the left 
ventricle systolic pressure with an appropriate pressure cuff 
based on age and RV/LV pressure ratio was estimated.9,10
Contrast echocardiography was performed for a better 
evaluation of intra cardiac shunts, especially in the ASD 
level. The width of the regurgitation jet determined the 
severity of the tricuspid regurgitation as mild, moderate, 
or severe.
The right ventricle size and function, severity of 
tricuspid and pulmonary regurgitation (PR), and intra-
atrial shunts in the ASD and patent ductus arteriosus 
(PDA) levels were evaluated post BPV and subsequently 1 
and 6 months afterward in the outpatient follow-up.
Anesthesia was induced in under the observation of 
a cardiac anesthesiologist. The drug protocol consisted 
of intravenous midazolam and ketamine. Tracheal 
intubation was performed according to the patient’s 
condition. Oxygen saturation, arterial blood O2 level, and 
blood pressure were continuously monitored during the 
procedure. The intracardiac pressure was measured with 
a fluid-filled catheter system. Before and after BPV, the 
RV/LV pressure ratio and the right ventricle to pulmonary 
artery gradient were measured. A 4-F or 5-F Judkins 
coronary catheter was placed in the RVOT, and a 0.014-
in guide wire was passed through the pulmonary valve 
into the ductus arteriosus and the descending aorta, if 
accessible, or the pulmonary branches.
Based on the severity of pulmonary stenosis, the balloon-
to-pulmonary valve annulus diameter was calculated and 
a proper balloon valvuloplasty catheter was selected. In 
some patients, balloon dilation was done with smaller 
balloon sizes and gradually larger balloons were selected 
until the maximal diameter was used. 
The BPV procedure was considered successful if the 
guide wire and the intended pulmonary balloon were 
successfully passed through the pulmonary valve and an 
appropriate waist was formed (Figure 1). 
The selection of the appropriate balloon size was 
based on the echocardiography and catheterization 
measurements. The diameter of the pulmonary valve 
annulus was measured in the short-axis view via 
echocardiography. During the cardiac catheterization, the 
diameter of the pulmonary annulus was calculated in the 
anteroposterior and lateral views after the injection of the 
contrast medium into the RV.
Also, we select the balloon type based on several factors 
including: the age and weight, ability of passing venous 
introducer sheaths, pulmonary valve cusp thickness, and 
limitation of pulmonary valves motion.
If the RV pressure after balloon pulmonary valvuloplasty 
dropped to less than 36 mm Hg, it was considered a 
normal RV pressure.
The procedure was deemed successful if the RV/
LV pressure gradient was decreased to below 50% of 
the left ventricle pressure or if the level of O2 saturation 
was increased to above 75% and Prostaglandin E1 was 
discontinued.
Statistical analysis
The continuous data with normal and non-normal 
distributions were reported with means and standard 
deviations, respectively, and the categorical data were 
reported with frequencies. The Kruskal–Wallis test, 
Pearson χ2 test, and Friedman test were applied for 
the statistical analyses. SPSS (IBM SPSS Statistics for 
Windows, version 22.0, Armonk, NY: IBM Corp) was 
used for all the analyses. 
Results
Forty-five patients, consisting of 23 (51.1%) males and 22 
(48.9%) females, at a mean body weight of 4.8(5.2 ± 1.8 
(kg were evaluated between May 2012 and July 2016. 
The demographic and data of Echocardiography 
and catheterization depicted in Table 1 and Table 2 
respectively. The types of balloons used for pulmonary 
valve valvuloplasty and degree of pulmonary valve 
regurgitation showed in Table 3.Dysplastic pulmonary 
valves were reported in 3 patients and PDAs with left-
to-right shunts and the supply of the pulmonary blood 
flow from the patent ductus arteriosus were observed in 
23 (51.1%). Prostaglandin E1 was initiated in 4 (8.8%) 
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patients because they had complete PDA dependent 
pulmonary blood circulations and severe cyanosis.
Electrocardiographic (ECG) findings
At the commencement of the study, all the patients had 
normal sinus rhythms on surface ECG. In most of them 
(77.7%), right frontal axis deviation was observed. Eight 
(17.7%) patients had normal axes and only 2 (4.4%) had 
superior axes. Patterns of right ventricle hypertrophy 
were observed in the ECG of the majority of the study 
population (93.3%), and 3 patients had left ventricle 
hypertrophy. 
Echocardiography findings
All the 45 patients had ASD or PFO. The tricuspid valve 
regurgitation was severe in 31.1% and moderate in 12.3% 
of the study patients, with the rest having mild TR. The 
RV size was normal (tricuspid valve Z-score > -2) in 28 
(62.2%) patients, small (tricuspid valve Z-score = -2 to 
-4) in 9 (20%), and larger than normal in 8 (17.8%). After 
the procedure, 32 (71.1%) patients had trivial-to-mild 
tricuspid valve regurgitation and only 1 patient had severe 
tricuspid valve regurgitation. The change in the severity 
of tricuspid valve regurgitation was significant after BPV 
(P = 0.034).
In the post- Balloon pulmonary valvuloplasty 
echocardiography, pulmonary regurgitation was severe in 
6 (14.2%) infants, moderate in 7 (15.5%), and mild in 32 
Figure 1 A: RV injection in Lateral view revealed Critical Valvar PS, Sever RVH,Small size RV,Elongated RVOT, Pin hole Fenestrated 
Pulmonary Valve, Doming and Thickening of Cusps.
B:DAO injection in Lateral View showed Tubular and long shape PDA , Significant Left to Right Shunt ,PA filling via PDA. C:Ante grade 
wiring of PA by CTO wire, PTPC by Mini- Tyshak Balloon size 7-20 mm. D:Final injection in RV at Lateral View showed opening of 
Pulmonary Valve, Patent and good ante grade Flow.
Table 1. Demographic , clinical and catheterization data of the patients with 
critical PS-IVS.
Variables (%) N 
Age 
 < 3 month 22(51.1)
 3–6 month 23(49.9)
Gender




and tracheal intubation 38 (84.4)
O2 saturation# 71%
ASD in patients 42(93.3)
PDA (with left to right shunt) 23(51.1)
PGE1 dependency 4(8.9)
ASD (with right-to-left shunting) 45(100)
PDA stenting 2 (4.4)
Balloon size/PV annulus
 <100% 1 (2.3)
 100–120% 36 (80)
 120–150% 8 (17.7)
BPV without Balloon predilation 32(71.1)
BPV with Balloon predilation 13(28.8)
Data expressed as number/percent except *as Kg (mean/SD ) and # as 
mean
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(71.1%).
Procedures
BPV procedure was performed successfully in all the 45 
cases. The level of O2 saturation was increased to above 
75% in 42 patients .The pulmonary balloon size was 
between 100% and- 120% of the diameter of the pulmonary 
valve annulus in 36 (80%) patients and between 120% and 
150% in 8 (17.7%). In 1 (2.2%) infant, the balloon size 
was smaller than the diameter of the pulmonary valve 
annulus because a larger balloon failed to pass through the 
pulmonary valve following coronary balloon predilation. 
Predilation of the balloon for the pulmonary valve was not 
required in 32 (71.1%) cases, while predilation was done 
in 13 (28.8%) with smaller to larger balloons sequentially 
in 2 to 3 steps with 0.014-in coronary guide wires. This 
procedure was repeated once more due to significant 
residual pulmonary stenosis after the first pulmonary 
valvuloplasty in 8 cases.
Of three cases that did not respond to initiate BPV, PDA 
stenting was done in 2 infants with Genesis Blue 4.5 Xorms 
stents. After PDA stenting, O2 saturation was increased, 
and the infants were extubated. During follow up, in first 
patient stent of PDA was occluded spontaneously and 
PTPC repeat again 1 year later and second patient refer to 
One and half repair surgery and PDA stent was occluded 
during surgery.
The RV was equal with the LV pressure in 23 (48.8%) 
cases and suprasystemic in 23 (51.1%). The RV dropped 
to less than 36 mm Hg immediately after the procedure 
in the catheterization laboratory in 8 (20%) infants. The 
immediate success rate was seen in 42 (93.3%) patients (the 
RV/LV pressure ratio dropped to < 50% or O2 saturation 
increased to > 75%). At 6 months’ follow-up, the right-to-
left ventricular pressure ratio was still within the normal 
range in 36 (80%) infants, but it had returned to high 
values in 9 (20%) and required repeat valvuloplasty. Of 
these 9 patients, three infants did not respond to repeat 
BPV and were, therefore, subjected to surgical valvotomy 
but six patients respond to BPV appropriately. During 
the follow-up, the change in the pressure was significant 
after 6 months (P = 0.009). Thirteen (28.8%) patients were 
treated with beta-blockers post procedurally and after 6 
months, the RV pressure was normal in this group.
The PDA remained patent 6 months after the 
valvuloplasty in 4 patients and it was closed via an 
interventional procedure, while the PDA closed 
spontaneously in the other patients. The ASD or PFO 
closed spontaneously in 33 (73.3%) infants.
Complications
Trauma to the vascular access was observed in 7 patients, 
all of whom were under 3 months old. In the presence of 
lower-limb pallor, coldness, and pulselessness, intravenous 
heparin was infused and 3 patients needed thrombolytic 
therapy.
There was 1 death in a neonate less than 1 month old 
due to procedural complications. This patient suffered 
the rupture of the RVOT during catheterization resulting 
in tamponade and underwent pericardiocentesis and 
urgent surgical pericardiotomy but expired 5 days later. 
The hospitalization period was less than 3 days in 3 
(6.6%) patients, 3 to 5 days in 20 (44.4%), 5 to 7 days in 14 
(31.1%), and more than 7 days in 8 (17.7%).
Discussion
Although in older studies the number of pulmonary 
balloon dilations and the immediate success rate were 
important, recent studies attach more significance to the 
mid- and long-term outcomes of the procedure and focus 
on several factors that may affect the outcome. In the 
present study, we comprehensively evaluated the outcome 
of the Balloon pulmonary valvuloplasty procedure in 
infants less than 6 months old with a 6-month follow-up. 
Table 2. Echocardiographic and catheterization data in the patients with 
critical PS-IVS before and 6 months after BPV.
Parameters before BPV after BPV
TV regurgitation
 Mild 25 (56.6) 32 (71)
 Moderate 6 (12.3) 12 (26.6)
 Severe 14 (31.1) 1 (2.2) 
PV regurgitation 
 Mild 32 (71) 
 Moderate 7 (15.5) 
 Severe 6 (14.2)
-TV Z-score
 > -2 28 (62.2) 
 -2 to -4 9 (20) 
 > 0 8 (17.8) 
Response to Therapy 
 Immediately after BPV 42 (93)
 After 6 months 36 (80) 
 Normal RV pressure (<36 mm Hg)
 Immediately after BPV 9 (20)
 After 6 months 36 (80) 
Data expressed as number/percent,BPV: Balloon pulmonary valvuloplasty
Table 3. The types of conventional balloons used for pulmonary valve 
valvuloplasty and degree of pulmonary valve regurgitation (PR) occurred 
with each type.
Type of balloon and patients number Mild Moderate Severe 
Minityshake (28) 24 2 2 
Tyshake (5) 5 0 0 
Sterling (3) 2 1 0
Z-Med 2,Z-Med x (3) 0 2 1
Evercross (4) 1 1 2
 Opta pro (2) 0 1 1
Data expressed as number
Mortezaeian et al
J Cardiovasc Thorac Res, 2021, 13(2), 156-161160
Immediate procedural success rate was 93% in our study. 
The overall success rate in different studies varies between 
85% to 87%. 11-13 Coronary balloon pre-dilation required 
in 29% of patients which was in line with Hassan et al 
(30%) but in Yucel et al study this rate was 18%. 13,14
After BPV by immediate procedural success rate, we 
observed a significant reduction in the RV pressure (<36 
mm Hg) in a small number of our patients (20%), which 
is consistent with other studies. 15-17 Nonetheless, at 6 
months’ follow-up, the RV had returned to the normal 
values in most of our patients (80%).
Humpl et al, 17 reported that after BPV on 30 patients, 
the mean RV was 42 mm Hg in 9 patients and 61 mm Hg 
in the remainder, who needed intervention. 
In our study, about one-third of cases has severe TR 
before procedure, nevertheless, at six month follow up, 
most (71%) had mild TR and only one patients had severe 
TR. Yucel et al , 14 observed moderate and severe TR in 
significant percentage of total 55 neonate respectively. The 
authors reported that the need for the augmentation of the 
blood flow after BPV was more in the patients with severe 
TR. Elsewhere, Saad et al, 11 studied 76 infants with severe 
PS and reported a reduction in the incidence of TR from 
56% to 20% at 6 months’ follow-up following BPV.
On echocardiography, larger RV is often accompanied 
by RV systolic dysfunction and severe TR. In cases 
with small right ventricle sizes (Z-score = -2 to -4) on 
echocardiography, the right ventricle cavity is severely 
hypertrophied but the systolic function is nearly normal. 
In this group of patients, right-to-left shunting via the 
interatrial communication and cyanosis are frequent.
In the current study, the majority of the patients with 
persistently high RV pressures at 6 months’ follow-up 
(20%) needed repeat valvuloplasty. Three cases failed to 
respond to valvuloplasty and underwent surgery. This 
condition occurred in a group with small, dysplastic, and 
thick pulmonary valves and severely hypertrophied high 
right ventricle chambers.
In our study, most patients were hospitalized for between 
3 and 7 days, but there was no significant correlation 
between age and the mean weight and the length of 
hospitalization. The median length of hospital stay was 
11.6 days in a study by Odemis et al, 18 on 15 neonates. 
In our study, we observed trauma to the vascular access 
in 7 patients, all of whom were under 3 months old. This 
rate chimes in with those reported by Chubb et al, 15 
and Humpl et al , 17. In study of Hoetama et al, BPV was 
done on 8 neonates with transjugular approach and they 
mentioned that using BPV with transjugular access is safe 
in neonate with critical PS. 19
We had 1 death (in 45 patients) due to RVOT rupture 
and tamponade. In the study by Chubb et al, 15 on 39 
neonates with Critical pulmonary stenosis or atresia 
with intact ventricular septum, the 30-day mortality after 
BPV was 6 patients, 2 of them died whom expired due 
to tamponade. Humpl et al 17 reported 5 postprocedural 
deaths (3 early and 2 late). 
In our study, the use of low-profile semicompliant 
balloons in most of the patients was correlated with mild 
post-procedural pulmonary regurgitation, whereas the 
use of high-profile noncompliant balloons was correlated 
with a higher incidence rate of moderate and severe PR. 
Moreover, when the balloon size was between 120% and 
150% of the diameter of the pulmonary valve annulus, 
there was a high degree of PR in comparison with when 
balloon sizes less than 120% were selected. Therefore, 
in our study, the factors with an impact on pulmonary 
regurgitation were balloon selection with sizes more 
than 1.2 the diameter of the pulmonary valve annulus, 
use of noncompliant high-pressure balloons, and larger 
right ventricle chambers and annuli. It seems that the 
prevention of severe PR requires not only the previous 
balloon-selection methods such as the diameter of the 
pulmonary valve annulus but also more accurate methods 
such as balloon selection based on the patient’s body 
surface area. 
factors that increase the probability of repeat BPV 
or surgery—including dysplastic pulmonary valves, 
pulmonary valve diameter, TV diameter, RV size 
(especially in cases with TV Z-scores between (-2 and -4), 
balloon size, and type and profile of the balloon.
Conclusion
The BPV procedure is now deemed conventional therapy 
for neonates and infants with PS-IVS. The treatment 
protocol, however, should be on a patient-by-patient basis 
because there are a number of factors—including the RV 
morphology, patient’s general condition, and issues related 
to the interventional procedure. In our study, the right 
ventricle indices were abnormal immediately after BPV, 
but our midterm follow-up demonstrated that the indices 
had returned to the normal values. Another salient point 
is that favorable results are dependent on the selection of 
proper balloons. Undoubtedly, further studies with longer 
follow-up durations are required to shed sufficient light 
on the other aspects of the management protocol. 
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